RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Dr. Black article on Phase 2 Trial of AtezolizumabWow 15 years and then another 15 years with TLT. You still haven't learned anything in 30 years in the markets. This is why these promoters are here because they know there are suckers like you born every day in the markets. Not trying to be mean but just giving you a reality check. Watch as another deadline will pass and it will be 2024, the promoters will still be here stringing you guys along. If people still don't get it, they never will. Cheers.
N0taP00p wrote: @Eoganacht: I had mentioned a medical devices company that I had invested in that had the greatest design.and I always thought next month, next quarter, next year will be better in terms of execution to the FDA submission timeline. I also believed management would have a lot of vested interest in being successful. Big names on the SAB. Well, that company has essentially folded into a provider of IPs. I was invested for 15 years with only losses to show for it. They could not execute to timelines nor raise money in a respectable way. The difference with TLT is that they at least have FTD and a phase 1 done. But everything else feels the same. Especially the inability to raise cash in a better way and what seems like a tendency to gloss over delays like it was always expected (or at least NOT being explicit about a delay being a delay in an NR). I also think their BOD should have had new and experienced faces a long time ago but without data, it was probably hard to attract namebrand talent. So if we give them the benefit of the doubt for being a scrappy startup that is trying to go it alone for 15 years, is it too much to expect better and transparent communications as the ONE ask? It goes back to the trust issue you mentioned. If next week they say BTD is delayed or give some kind of sloppy timeline update, it will prove my point. Let's hope it's not the case. Let's hope it's the announcement of BTD+AA.
Eoganacht wrote: Hi Oilminerdeluxe. I agree. There have been times in the last 9 years when I have questioned the wisdom of some of the actions of Theralase management, but I have never questioned their good faith. I believe Theralase management is doing it's level best to advance the interests of the company and it's shareholders. If I didn't believe this I don't know how I could stay invested. The science may be great but if you can't trust the people running things why would you risk your money on their decisions?
I'm sure there is a good reason BTD was delayed because I'm sure that, just like us, management would like nothing better than to be granted BTD and AA as soon as possible.
Oilminerdeluxe wrote: I know I sound boring, but if they have not applied yet, there is probably a very good reason for that. They must have gotten advice which they follow on the matter. I admit, I can be very wrong, but it sounds logical to me.